Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma

There is no standard third-line or further systemic treatment for patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma (NPC). Metronomic oral cyclophosphamide provides an acceptable and cheap option for these heavily pretreated patients who had limited ch...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Lee, Victor H.F., Kwong, Dora L.W., Lam, Ka-On, Lai, Yu-Ching, Li, Yun, Tong, Chi-Chung, Ho, Patty P.Y., Chan, Wing-Lok, Wong, Lai-San, Leung, Dennis K.C., Chan, Sum-Yin, Chan, Fong-Ting, Leung, To-Wai, Lee, Anne W.M.
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2017
Subjects:
5700
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403079/
https://ncbi.nlm.nih.gov/pubmed/28403082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006518
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items